EUVIMEDEUVIMED entdecken
Open Access

Ubiquitin-specific protease 1 facilitates tumor immune escape from natural killer cells and predicts the prognosis in small cell lung cancer

Shiqin Jiang, Yichun Tang, Feng Ma, Yuchun Niu, Lei Sun

Oncology Research · 2025

DOI: 10.32604/or.2024.046895 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2025. Verfasst von Shiqin Jiang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, 518104, China. Hauptthemen laut MEDLINE: Killer Cells, Natural, Lung Neoplasms, Small Cell Lung Carcinoma, Ubiquitin-Specific Proteases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Small cell lung cancer (SCLC) is commonly recognized as the most fatal lung cancer type. Despite substantial advances in immune checkpoint blockade therapies for treating solid cancers, their benefits are limited to a minority of patients with SCLC. In the present study, novel indicators for predicting the outcomes and molecular targets for SCLC treatment were elucidated.

Methods

We conducted bioinformatics analysis to identify the key genes associated with tumor-infiltrating lymphocytes in SCLC. The functional role of the key gene identified in SCLC was determined both in vitro and in vivo.

Results

A significant correlation was observed between patient survival and CD56dim natural killer (NK) cell proportion. Furthermore, we noted that the hub gene ubiquitin-specific protease 1 (USP1) is closely correlated with both CD56dim NK cells and overall survival in SCLC. Bioinformatics analysis revealed that USP1 is upregulated in SCLC. In addition, gene set enrichment analysis revealed that USP1 overexpression hinders NK cell-mediated immune responses. By co-cultivating NK-92 cells with SCLC cells, we demonstrated that NK cell cytotoxicity against SCLC could be improved either via USP1 knock-down or pharmacological inhibition. Furthermore, using a nude-mice xenograft tumor model, we noted that USP1 inhibition effectively suppressed tumor proliferation and increased the expression of NK cell-associated markers.

Conclusions

Our study findings highlight the importance of NK cells in regulating SCLC. USP1 overexpression can inhibit NK cell-mediated immunity; therefore, USP1 may serve not only as a prognostic biomarker but also as a potential molecular target of SCLC therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalLung NeoplasmsSmall Cell Lung CarcinomaUbiquitin-Specific ProteasesHumansAnimalsPrognosisMiceCell Line, TumorTumor EscapeXenograft Model Antitumor AssaysComputational BiologyMice, NudeFemaleBiomarkers, TumorGene Expression Regulation, NeoplasticCell ProliferationMaleLymphocytes, Tumor-Infiltrating

Stichwörter der Autor:innen

Immune escapeNatural killer (NK) cellPrognosisSmall cell lung cancer (SCLC)Ubiquitin-specific protease 1 (USP1)

Substanzen

Ubiquitin-Specific ProteasesBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, 518104, China.
  • Department of Pathology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, China.
  • Department of Radiation Oncology, The First People's Hospital of Foshan, Foshan, 528000, China.
  • Department of Oncology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, 510630, China.
  • Department of Oncology, The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, 523721, China.

Zitieren

APA

Jiang, S., Tang, Y., Ma, F., Niu, Y., & Sun, L. (2025). Ubiquitin-specific protease 1 facilitates tumor immune escape from natural killer cells and predicts the prognosis in small cell lung cancer. Oncology Research. https://doi.org/10.32604/or.2024.046895

Vancouver

Jiang S, Tang Y, Ma F, Niu Y, Sun L. Ubiquitin-specific protease 1 facilitates tumor immune escape from natural killer cells and predicts the prognosis in small cell lung cancer. Oncology Research. 2025. doi:10.32604/or.2024.046895

BibTeX
@article{Jiang2025,
  author = {Jiang, Shiqin and Tang, Yichun and Ma, Feng and Niu, Yuchun and Sun, Lei},
  title = {Ubiquitin-specific protease 1 facilitates tumor immune escape from natural killer cells and predicts the prognosis in small cell lung cancer},
  journal = {Oncology Research},
  year = {2025},
  doi = {10.32604/or.2024.046895}
}
Kostenlos starten →